The insulin-like growth factor axis and growth in children with chronic renal failure: A report of the southwest pediatric nephrology study group

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 5, 1998, Pages 1654-1661

  Powell, David R ^a,f   Durham, Susan K ^a   Liu, Frances ^b   Baker, Bonita K ^b   Lee, Phillip D K ^a   Watkins, Sandra L ^c   Campbell, Phil G ^d   Brewer, Eileen D ^a   Hintz, Raymond L ^b,e   Hogg, Ronald J ^g  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^e Cleft Lip and Palate Treatm Center   (United States)

^f TEXAS CHILDREN S HOSPITAL   (United States)

^g NONE

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; HUMAN GROWTH HORMONE; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ARTICLE; CATCH UP GROWTH; CHILD GROWTH; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; GEL PERMEATION CHROMATOGRAPHY; GROWTH DISORDER; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; GROWTH INHIBITION; HUMAN; IMMUNOREACTIVITY; MENTAL DEFICIENCY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STOICHIOMETRY; SUBCUTANEOUS DRUG ADMINISTRATION;

CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, GEL; FEMALE; GROWTH; HUMAN GROWTH HORMONE; HUMANS; IMMUNOBLOTTING; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; KIDNEY FAILURE, CHRONIC; MALE;

EID: 7844235112     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.5.1654     Document Type: Article

References (48)

1. Isaakson OGP, Lindahl A, Nilsson A, Isgaard J. 1987 Mechanism of the stimulatory effect of growth hormone on longitudinal bone growth. Endocr Rev. 8:426-438.
2. Vaccarello MA, Diamond FB, Guevara-Aguirre J, et al. 1993 Hormonal, metabolic and pharmacokinetic effects of recombinant insulin-like growth factor-I in growth hormone receptor deficient (GHRD) syndrome. J Clin Endocrinol Metab. 77:273-280.
3. Cox GN, McDermott MJ, Merkel E, et al. 1994 Recombinant human insulin-like growth factor (IGF) binding protein-1 inhibits somatic growth stimulated by IGF-I and growth hormone in hypophysectomized rats. Endocrinology. 135:1913-1920.
4. Schoenle E, Zapf J, Hauri C, Steiner T, Froesch ER. 1985 Comparison of in vivo effects of insulin-like growth factors I and II and of growth hormone in hypophysectomized rats. Acta Endocrinol (Copenh). 108:167-174.
5. Powell DR, Liu F, Baker BK, et al. 1997 Modulation of growth factors by growth hormone in children with chronic renal failure. Kidney Int. 51:1970-1979.
6. Shimasaki S, Shimonaka M, Zhang H-P, Ling N. 1991 Identification of five different insulin-like growth factor binding proteins (IGFBPs) from adult rat serum and molecular cloning of a novel IGFBP-5 in rat and human. J Biol Chem. 266:10646-10653.
7. Shimasaki S, Gao L, Shimonaka M, Ling N. 1991 Isolation and molecular cloning of insulin-like growth factor binding protein-6. Mol Endocrinol. 5:938-948.
8. Baxter RC, Martin JL. 1989 Binding proteins for the insulin-like growth factors: structure, regulation and function. Prog Growth Factor Res. 1:49-68.
9. Martin JL, Baxter RC. 1986 Insulin-like growth factor binding proteins from human plasma. J Biol Chem. 264:11843-11848.
10. Baxter RC, Martin JL, Beniac VA. 1989 High molecular weight insulin-like growth factor binding protein complex. J Biol Chem. 264:11843-11848.
11. Powell DR. 1989 Renal disease and growth retardation. Kidney. 22:7-12.
12. Powell DR, Liu F, Baker BK, Lee PDK, Hintz RL. 1996 Insulin-like growth factor binding proteins as growth inhibitors in children with chronic renal failure. Pediatr Nephrol. 10:343-347.
13. Powell DR, Rosenfeld RG, Baker BK, Hintz RL. 1986 Serum somatomedin levels in adults with chronic renal failure: the importance of measuring insulin-like growth factor (IGF)-I and IGF-II in acid-chromatographed uremic serum. J Clin Endocrinol Metab. 63:1186-1192.
14. Powell DR, Rosenfeld RG, Sperry JB, Baker BK, Hintz RL. 1987 Serum concentrations of insulin-like growth factor (IGF)-1, IGF-2 and unsaturated somatomedin carrier proteins in children with chronic renal failure. Am J Kidney Dis. 10:287-292.
15. Phillips LS, Fusco AC, Unterman TG, DelGreco F. 1984 Somatomedin in hibitor in uremia. J Clin Endocrinol Metab. 59:764-772.
16. Blum WF, Ranke MB, Kietzmann K, Tonshoff B, Mehls O. 1991 Growth hormone resistance and inhibition of somatomedin activity by excess of insulin-like growth factor binding protein in uraemia. Pediatr Nephrol. 5:539-544.
17. Tonshoff B, Mehls O, Heinrich U, Blum WF, Ranke MB, Schauer A. 1990 Growth-stimulating effects of recombinant human growth hormone in children with end-stage renal disease. J Pediatr. 116:561-566.
18. Hokken-Koelega ACS, Stijnen T, de Muinck Keizer-Schrama SMPF, et al. 1991 Placebo-controlled, double-blind, cross-over trial of growth hormone treatment in prepubertal children with chronic renal failure. Lancet 338:585-590.
19. Powell DR, Rosenfeld RG, Hintz RL. 1988 Effects of growth hormone therapy and malnutrition on the growth of rats with renal failure. Pediatr Nephrol. 2:425-430.
20. Powell DR, Lee PDK, Chang D, Liu F, Hintz RL. 1987 Antiserum developed for the E peptide region of insulin-like growth factor-IA prohormone recognizes a serum protein both by immunoblot and by RIA. J Clin Endocrinol Metab. 65:868-875.
21. Baxter RC, Martin JL. 1986 Radioimmunoassay of growth hormone-dependent insulin-like growth factor binding protein in human plasma. J Clin Invest. 78:1504-1512.
22. Liu F, Powell DR, Hintz RL. 1990 Characterization of insulin-like growth factor binding proteins in human serum from patients with chronic renal failure. J Clin Endocrinol Metab. 70:620-628.
23. Lee PDK, Hintz RL, Sperry JB, Baxter RC, Powell DR. 1990 Insulin-like growth factor binding proteins in growth retarded children with chronic renal failure. Pediatr Res. 26:308-315.
24. Lee PDK, Conover CA, Powell DR. 1993 Regulation and function of insulin-like growth factor binding protein-1. Proc Soc Exp Biol Med. 204:4-29.
25. Powell DR, Liu F, Baker B, et al. 1993 Characterization of insulin-like growth factor binding protein-3 in chronic renal failure serum. Pediatr Res. 33:136-143.
26. Blum WF, Horn N, Kratzsch J, et al. 1993 Clinical studies of IGFBP-2 by radioimmunoassay. Growth Regul. 3:100-104.
27. Tonshoff B, Blum WF, Wingen A-M, Mehls O. 1995 Serum insulin-like growth factors (IGFs) and IGF binding proteins 1, 2 and 3 in children with chronic renal failure: relationship to height and glomerular filtration rate. J Clin Endocrinol Metab. 80:2684-2691.
28. Kale AS, Liu F, Hintz RL, et al. 1996 Characterization of insulin-like growth factors (IGFs) and IGF binding proteins in peritoneal dialysate. Pediatr Nephrol. 10:467-473.
29. Powell DR, Liu F, Baker BK, et al. 1997 Insulin-like growth factor binding protein-6 levels are elevated in serum of children with chronic renal failure. J Clin Endocrinol Metab. 82:2978-2984.
30. Mehls O, Tonshoff B, Blum WF, Heinrich U, Seidel C. 1990 Growth hormone and insulin-like growth factor I in chronic renal failure: pathophysiology and rationale for growth hormone treatment. Acta Paediatr Scand. 370(Suppl):28-34.
31. Valentinis B, Bhala A, DeAngelis T, Baserga R, Cohen P. 1995 The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene. Mol Endocrinol. 9:361-367.
32. DeMellow JSM, Baxter RC. 1988 Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I-stimulated DNA synthesis in human skin fibroblasts. Biochem Biophys Res Commun. 156:199-204.
33. Conover CA, Ronk M, Lombana F, Powell DR. 1990 Structural and biological characterization of bovine insulin-like growth factor binding protein-3. Endocrinology. 127:2795-2803.
34. Conover CA. 1992 Potentiation of insulin-like growth factor (IGF) action by IGF-binding protein-3: studies of underlying mechanism. Endocrinology. 130:3191-3199.
35. Conover CA. 1991 Glycosylation of insulin-like growth factor binding protein-3 (IGFBP-3) is not required for potentiation of IGF-I action: evidence for processing of cell-bound IGFBP-3. Endocrinology. 129:3259-3268.
36. Durham SK, Mohan S, Liu F, et al. 1997 Bioactivity of a 29 kDa IGFBP-3 fragment present in excess in chronic renal failure serum. Pediatr Res. 42:335-341.
37. Hintz RL, Liu F, Rosenfeld RG, Kemp SF. 1981 Plasma somatomedin-binding proteins in hypopituitarism: changes during growth hormone therapy. J Clin Endocrinol Metab. 53:100-104.
38. Giudice LC, Farrell EM, Pham H, Lamson G, Rosenfeld R. 1990 Insulin-like growth factor binding proteins in maternal serum throughout gestation and in the puerperium; effects of a pregnancy-associated protease activity. J Clin Endocrinol Metab. 71:806-816.
39. Liu F, Powell DR, Styne DM, Hintz RL. 1991 Insulin-like growth factors (IGFs) and IGF binding proteins in the developing Rhesus monkey. J Clin Endocrinol Metab. 72:905-911.
40. Liu F, Hintz RL, Khare A, DiAugustine RP, Powell DR, Lee PDK. 1994 Immunoblot studies of the IGF-related acid-labile subunit. J Clin Endocrinol Metab. 79:1883-1886.
41. Gargosky SE, Pham HM, Wilson KF, Liu F, Giudice LC, Rosenfeld RG. 1992 Measurement and characterization of insulin-like growth factor binding protein-3 in human biological fluids: discrepancies between radioimmunoassay and ligand blotting. Endocrinology. 131:3051-3060.
42. Goldberg AC, Trivedi B, Delmez JA, Harter HR, Daughaday WH. 1982 Uremia reduces serum insulin-like growth factor I, increases insulin-like growth factor II, and modifies their serum protein binding. J Clin Endocrinol Metab. 55:1040-1045.
43. Baxter RC, Martin JL. 1989 Structure of the Mr 140,000 growth hormone-dependent insulin-like growth factor binding protein complex: determination by reconstitution and affinity labeling. Proc Natl Acad Sci USA. 86:6898-6902.
44. 125I]IGF-I. J Clin Endocrinol Metab. 80:1318-1324.
45. Lee CY, Rechler MM. 1995 Purified rat acid-labile subunit and recombinant human insulin-like growth factor (IGF) binding protein-3 can form a 150 kD binary complex in the absence of IGFs. Endocrinology. 136:4982-4989.
46. Lee CY, Rechler MM. 1995 A major portion of the 150 kilodalton insulin-like growth factor binding protein (IGFBP) complex in adult rat serum contains unoccupied, proteolytically nicked IGFBP-3 that binds IGF-II preferentially. Endocrinology. 136:668-678.
47. Lee CY, Rechler MM. 1996 Proteolysis of insulin-like growth factor (IGF) binding protein-3 (IGFBP-3) in 150 kilodalton IGFBP complexes by a cation-dependent protease activity in adult rat serum promotes the release of bound IGF-I. Endocrinology. 137:2051-2058.
48. Binoux M, Hossenlopp P. 1988 Insulin-like growth factor (IGF) and IGF-binding proteins: comparison of human serum and lymph. J Clin Endocrinol Metab. 67:509-514.